Skip to content

Treatment of Intrabony Defect in Patient With Periodontitis Stage III by Using I-PRF and Xenograft

Injectable Platelet Rich Fibrin (I-PRF) With Xenograft in Intrabony Defects of Periodontitis Patient Stage III Versus Xenograft Alone

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07261878
Enrollment
20
Registered
2025-12-03
Start date
2025-02-17
Completion date
2026-12-17
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrabony Defect, Intrabony Defects in Chronic Periodontitis

Keywords

I-PRF with xenograft

Brief summary

Evaluate of the injectable platelet rich fibrin (I-PRF) with xenograft in Intrabony defects of Periodontitis patient stage III versus Xenograft alone.

Detailed description

All surgical procedures will be conducted by a single operator. Following administration of local anesthesia, intrasulcular incisions will beperformed buccally and lingually/palatally on the affected tooth and extended one adjacent tooth mesially and distally, using 15c blades. Following mucoperiosteal flap elevation, thorough debridement will be performed using ultrasonic scalers and curettes until defects are clear from any granulation tissue, and the defect morphology will be visually explored and recorded. In the group1: xenograft alone(Bovin xenograft)will be applied to the intrabony defect area. In the group 2: xenograft (Bovin xenograft) with injectable platelet Rich fibrin (I- PRF) will be applied to the intrabony defect area. Preperation of Injectable platelate Rich Fibrin (I-PRF) : will be prepared for each patient as follows: 5 ml of venous blood will be collected from the patient blood then placed in a plastic tube without any added material or coagulant and centrifuged at 700 rpm for 3 min. then mixed with Xenograft. Finally, the flap will be passively repositioned using interrupted 4-0 silk

Interventions

PROCEDUREinjectable platelet rich fibrin and xenograft

Elevation of papilla preservation flap at the site of 3mm infrabony defect ,prepearing the I-PRF which is obtained from the patients own blood , centrifuged at 700 rpm in 3 min and mixed with xenograft than placed at the defect area after removal all the granulation tissue follow up after 3 and 6 months intervals

Elevation of papilla preservation flap at the site of 3mm infrabony defect after removal all the granulation tissue, the xenograft alone inserted to the defect, suturing and follow up after 3 and 6 months intervals

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patient should have localized Periodontitis stage III grade B with pocket depth ≥ 6mm; indicated for periodontal surgery 2. Patient's agreement to the surgical procedure and clinical trial. 3. Age ranged between 30-55 years old. 4. Intrabony defects with depth ≥3mm. 5. Free from any systemic conditions and no previous drug affect bone metabolism

Exclusion criteria

1. Smoking. 2. Pregnant women. 3. Patients in variation in anatomical landmarks. 4. Patients with psychological problems. 5. Patients with abnormal habits.

Design outcomes

Primary

MeasureTime frameDescription
Radiographic parameters6 months after treatment• The bone fill after 6 months postoperatively using digital periapical radiography using parallel technique.

Secondary

MeasureTime frameDescription
Pocket depth (PD)presurgically, 3 and 6 months interval after treatmentwill be assessed by William graduated periodontal Probe in 4 surfaces of the tooth
Plaque index (PI)pre-surgically 3 months and 6 months respectivelyAccording to Silness & Loe, 4 readings will be recorded for each surface of the teeth (buccal, lingual, mesial and distal) and it is given a score from 0-3
Gingival index (GI)pre-surgically 3 months and 6 months respectivelypresence or absence of bleeding on upon gentle probing
Clinical attachment level (CAL)pre-surgically 3 months and 6 months respectivelywill be measured from the cement-enamel junction to the base of the pocket

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026